Webinar on-demand: Scalable Logistics for Cell and Gene Therapies

By Simon Ellison |

Using case studies and then applying academic principles, this webinar looks at the value of planning logistics early in the development of cell and gene therapies.
More traditional therapies have elongated clinical trials and established supply chains. However cell and gene therapies are moving from Phase I to marketing authorization application in 5 years, and have complicated temperature-critical, time-sensitive logistics requirements.

It is valuable, therefore, to have a vision for the commercial supply chain and use the clinical trial process to build, test and optimize the logistics platform ready for commercial launch.

Learning Outcomes

The value of planning early
The impact of poor logistics on a therapy's ability to treat patients
The complexity of cell and gene therapy supply chains
How to develop a logistics platform that can support clinical trials but be able to grow into commercial scale

In Collaboration with

             

 

Speakers

Joshua Anderson
Senior Manager, Clinical Supply Operations           
Adaptimmune 
  Simon Ellison
Cell and Gene Therapy Service Director                
World Courier
  Ryan McCoy
Lead Technical Scientist                                      
Cell and Gene Therapy Catapult



About the Author

A portrait of Simon Eliison.

Simon Ellison

Cell and Gene Therapy Service Director from Sep ’17 – April ’20
World Courier
Simon Ellison, our Service Director for Cell and Gene Therapy, passed away in April 2020. Simon leaves a lasting legacy at World Courier and a distinctive mark on the advanced therapy logistics industry. His mission goes on with all of us to deliver cell and gene therapy treatments to patients in need.
View Bio